Project Details
Description
A Phase Ib Trial of Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/18 → 5/31/22 |
Funding
- CLEVELAND CLINIC
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.